Aggregated News From Investment Management Regulators

Publication of financial reports: Federal Office of Justice imposes disciplinary fine against Elanix Biotechnologies AG

Report/Flag

Please complete the required fields.



On 26 March 2020, the Federal Office of Justice (Bundesamt für JustizBfJ) imposed a disciplinary fine amounting to 2,500 euros against Elanix Biotechnologies AG.

The disciplinary fine order related to a breach of section 325 of the German Commercial Code (HandelsgesetzbuchHGB) by Elanix Biotechnologies AG. Elanix Biotechnologies AG had failed to submit its consolidated accounting documents for the financial year 2018 for the purpose of disclosure to the operator of the German Federal Gazette (Bundesanzeiger) in electronic form within the prescribed period within the prescribed period. The legal basis for the sanction is section 335 of the HGB.

The company can lodge a complaint against the disciplinary fine order.

Regulator Information

Recent Articles

Elliott Investment, website operator of elliott-investment.com: suspected violation of the prospectus requirement

Offering securities to the public without an approved prospectus constitutes a violation of the prospectus requirement under Article 3(1) of the EU Prospectus Regulation – unless an exemption applies

Grand-ducal Regulation of 27 July 2022

Grand-ducal Regulation of 27 July 2022, amending Grand-ducal Regulation of 30 May 2018 on the protection of financial instruments and funds belonging to clients,...

MFSA Warning – 86FXTRADE & P240 Ltd – Unlicensed Exchange

The Malta Financial Services Authority (“MFSA”) has become aware of an entity operating under the names of 86FXTRADE and/or P240 Ltd (“the Entity”) which has an internet presence at https://www.

Get the latest from Regulatory.News in your inbox!

×